Wegovy Injection Pen – 1.7 mg x 4 Doses (Semaglutide)

Wegovy Injection Pen contains semaglutide, a medication that mimics the naturally occurring hormone GLP-1 (glucagon-like peptide-1), which regulates appetite and glucose metabolism. By activating GLP-1 receptors in the brain, semaglutide helps reduce hunger, increase satiety, and slow gastric emptying, which can help reduce overall calorie intake.

The 1.7 mg dose is an advanced step in the Wegovy treatment schedule, following initial lower doses, allowing patients to achieve stronger therapeutic effects while minimizing side effects through gradual titration.

Each pen is pre-filled for once-weekly subcutaneous injection, providing an easy-to-use option for home administration as part of a structured weight management program.

Enhanced appetite control
Semaglutide helps regulate hunger signals, reducing cravings and supporting reduced calorie intake.

Supports sustainable weight management
By promoting fullness and helping control food intake, the medication may aid in gradual, consistent weight loss.

Stepwise dose escalation
The 1.7 mg dose is introduced after lower doses, allowing the body to adapt while maximizing efficacy.

Convenient weekly injection
The pre-filled pen provides a simple and reliable once-weekly dosing routine.

Supports metabolic health
Improved appetite regulation and glucose metabolism may contribute to better long-term metabolic outcomes.

Wegovy (Semaglutide) Injection Pen – 1.7 mg is administered as a subcutaneous injection once per week.

General usage guidelines:

• Inject once weekly on the same day each week.

• The injection may be administered with or without food.

• Recommended injection sites include the abdomen, thigh, or upper arm.

• Rotate injection sites to reduce the risk of irritation.

• Follow the dosing schedule provided by a healthcare professional.

The 1.7 mg dose is typically used after completing the 0.25 mg, 0.5 mg, and 1 mg starting phases, as part of the structured Wegovy dose escalation plan.

For optimal results, treatment should be combined with healthy diet, portion control, and regular physical activity.

Wegovy (Semaglutide) should be used under the supervision of a qualified healthcare professional.

Important precautions:

• Common side effects may include nausea, vomiting, diarrhea, constipation, or decreased appetite.

• Inform your healthcare provider about any pre-existing medical conditions or medications before starting treatment.

• Individuals with a personal or family history of thyroid disorders should consult a healthcare professional before use.

• Do not use if allergic to semaglutide or any component of the formulation.

• Store the injection pen according to manufacturer guidelines, typically refrigerated until use.

If severe side effects or allergic reactions occur, discontinue use and seek immediate medical attention.